BeStock  
Markets › Compare › ANNX vs LXRX

ANNX vs LXRX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ANNX · Annexon$4.01 ▼ 0.50%
LXRX · Lexicon Pharmaceuticals$1.76 ▲ 0.57%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

61101142182222Oct 9, '25Apr 9, '26Oct 7, '26
  • ANNX +23.0%
  • LXRX +7.3%

Head to head

MetricANNXLXRX
Price$4.01$1.76
Change today▼ 0.50%▲ 0.57%
Market cap$760.21M$783.12M
Return, 3 months-32.5%-21.8%
Return, year to date-20.1%+53.0%
Return, 1 year+27.3%+23.1%
P/E (TTM)-3.5-11.0
P/B4.14.5
P/E percentile vs own 5y34th12th
Dividend yield––
Revenue growth (YoY, latest qtr)–-97.6%
Net profit growth (YoY)-12.6%-1,077.1%
Gross margin–99.1%
Operating margin–-131.4%
Net margin–-147.4%
Return on equity-104.3%-40.2%
Analyst target vs. price+252.6%+228.4%
Analyst buy share75%100%
RSI (14)4133
30-day volatility60.5%51.5%
Max drawdown, 1 year-47.7%-34.1%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • LXRX is the largest of the group by market value.
  • ANNX has returned the most over the past year.
  • LXRX carries the lowest trailing P/E.
  • LXRX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top